Panel Proposes Rules for Research Abroad

Publisher Website
Google Scholar
Abstract
Before scientists begin a clinical study in the developing world, they should make sure any successful treatment that results will be made available not just to trial participants but to the whole host country, according to a controversial recommendation from a presidential panel. The U.S. National Bioethics Advisory Commission (NBAC) on 29 September released draft guidelines that would set this high bar for clinical research in foreign countries. NBAC took up the issue last year in response to controversies over placebo-controlled trials involving HIV-infected mothers and international trials of AIDS vaccines.

This publication has 0 references indexed in Scilit: